Early and Late Implant Failure: Differential Diagnosis and Management Strategies

Implant failure is an event every clinician encounters, and its management distinguishes clinical maturity more than most other situations. The fundamental distinction, introduced by Esposito in 1998 and still valid, separates EARLY failures — occurring before prosthetic loading, from absent osseointegration — from LATE failures, affecting an already integrated, functioning implant.

This is not a chronological distinction but a causal one: the two categories have entirely different aetiologies, clinical presentations and prognoses. Confusing them leads to ineffective treatment, and most management errors arise precisely from applying early-failure reasoning to a late failure.

Early failure reflects the bone's inability to form direct contact with the implant surface. There are three main causes. Overheating during site preparation, producing bone necrosis when temperature exceeds 47 degrees for more than a minute: this is why abundant irrigation and sharp drills are not recommendations but requirements.

The second cause is insufficient primary stability. Micromovement above 100 to 150 micrometres during healing prevents direct bone deposition and leads to fibrous tissue at the interface. The implant is clinically mobile on examination, and no additional waiting can correct the picture: fibrous encapsulation, once established, is irreversible.

The third is bacterial contamination of the site, which in immediate post-extraction cases is associated with active periapical lesions not adequately curetted. Residual infected granulation tissue compromises healing from the outset, and the implant typically fails within the first four to eight weeks.

Diagnosis of early failure is essentially clinical: implant mobility on percussion or manual testing, a dull sound on percussion instead of the ringing note characteristic of osseointegration, continuous peri-implant radiolucency. A mobile implant is a failed implant, without exception and without possibility of salvage.

Late failure has an entirely different dynamic. The implant integrated and functioned, then began losing supporting bone. The two dominant causes are peri-implantitis, infective in nature, and occlusal overload, biomechanical in nature. Distinguishing them is not always straightforward and the two mechanisms often coexist.

Peri-implantitis presents with bleeding on probing, suppuration in roughly half of cases, increased probing depths and crater-shaped bone loss around the implant, generally symmetrical. The implant remains stable until loss is advanced: mobility appears late and is an ominous prognostic sign, not an early diagnostic criterion.

Occlusal overload produces a different picture. Bone loss tends to be more localised, often asymmetrical in the direction of the prevailing force, and is associated with mechanical signs: recurrent screw loosening, veneer fracture, marked wear facets. Soft tissue inflammation is present but typically less intense than in peri-implantitis.

The distinction has direct practical consequences. Treating overload with decontamination protocols without correcting the occlusion produces systematic relapse; conversely, rebalancing occlusion without addressing the infective component allows bone loss to progress. The correct approach addresses both components when both are present.

The decision between retention and removal is the most delicate moment. Criteria favouring removal include implant mobility, bone loss exceeding two-thirds of the length, involvement of critical anatomical structures, and failure of at least one correctly conducted treatment attempt.

The most frequent error is therapeutic persistence. An implant with advanced bone loss, subjected to repeated regenerative treatments failing one after another, consumes bone that would have served re-implantation and needlessly prolongs a course whose outcome is already written. Removing early leaves more options than removing late.

Removal technique has implications for the future site. Counter-torque, using reverse rotation applied with dedicated instrumentation, is preferable where bone loss permits: it preserves residual bone because it requires no osteotomy. Trephine burs instead sacrifice a ring of bone around the implant and should be reserved for cases where counter-torque fails.

Re-implantation in the failed site is possible and well documented, but with lower success rates than the first implant: series report survival around 90 per cent against 96 to 98 for primary implants. The difference is explained by the quality of regenerated bone and, plausibly, by individual susceptibility factors that do not disappear with removal.

Re-implantation timing depends on the cause of failure. After early failure without infection, immediate re-implantation in the same procedure is possible if primary stability can be achieved in healthy bone. After peri-implantitis it is preferable to await complete tissue healing — typically three to six months — often with concurrent or preliminary bone regeneration.

In conclusion, managing failure requires above all a correct diagnosis of the category: early or late, infective or mechanical. Everything else follows from that classification. And it requires willingness to communicate a failure to the patient, which is the hardest part: clinical experience shows that patients accept a clearly explained, promptly addressed failure far better than a minimised problem dragged out over time.